Vol 14, No 4 (August 25, 2025) - Chinese Clinical Oncology

Editorial

Oligometastatic prostate cancer: new horizons for local treatment with the androgen receptor target therapy

Giulio Francesco Reale, Riccardo Scarlatti, Diana Aresu

Chinese Clinical Oncology

2025;

14

(4)

:37

.

(25 August 2025)

PDF Full Text (334) Peer Review File COI Form Open Access

Original Article

Alkylating agent-associated fertility impairment in female adolescents and young adults with acute leukemia

Peiwen Zhang, Zhe Wang, Qihong Wan, Yue Zhang, Enchun Li, Lijun Yin, Xinying Yu, Xiaowei Shi, Jianhua Qian

Chinese Clinical Oncology

2025;

14

(4)

:38

.

(25 August 2025)

PDF Full Text (479) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Bibliometric and visualization analysis of cancer associated with intestinal flora through genetics and epigenetics from 1991 to 2024

Yang Li, Keyi Shi, Hengyi Qi, Wentian Cui, Qian Cai, Tizhen Yan, Baobiao Zhuo, Weiwei He

Chinese Clinical Oncology

2025;

14

(4)

:39

.

(25 August 2025)

PDF Full Text (336) Reporting Checklist Peer Review File COI Form Open Access

Hot spots and trends related to chemotherapy in nasopharyngeal carcinoma [2014–2024]: a bibliometric study

Han Deng, Peng Zhou, Suyu Wang, Qicheng Zhang

Chinese Clinical Oncology

2025;

14

(4)

:40

.

(25 August 2025)

PDF Full Text (317) Reporting Checklist Peer Review File COI Form Open Access

Review Article

New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?—a narrative review

Fabrizio Di Costanzo, Iolanda Santa Parisi, Giuseppe Neola, Fabiano Flauto, Giovanna Pecoraro, Luigi Formisano, Vincenza Conteduca, Chiara Mercinelli, Brigida Anna Maiorano, Giuseppe Luigi Banna, Michele Maffezzoli, Sebastiano Buti, Giuseppe Fornarini, Sara Elena Rebuzzi, Davide Campobasso, Robert Chandler, Christoph Oing, Pasquale Rescigno

Chinese Clinical Oncology

2025;

14

(4)

:41

.

(25 August 2025)

PDF Full Text (511) Reporting Checklist Peer Review File COI Form Open Access

Narrative review on immune-related adverse events (irAEs) of immune checkpoint inhibitors in the adjuvant therapy of urological cancers

Riya Sabharwal, Artur Vysotskyi, Giuseppe Luigi Banna, Akash Maniam

Chinese Clinical Oncology

2025;

14

(4)

:42

.

(25 August 2025)

PDF Full Text (399) Reporting Checklist Peer Review File COI Form Open Access

Nutrition in lung cancer treatment: the forgotten pillar of care?

José Pablo Miramontes-González, Álvaro Rodrigo-Alaíz, Laisa Briongos-Figuero, Alejandro Olivares-Hernández, Juana Carretero-Gómez, Miriam Gabella-Martín, Julia Sebastián-Rodríguez, Luis Corral-Gudino

Chinese Clinical Oncology

2025;

14

(4)

:43

.

(25 August 2025)

PDF Full Text (1488) Peer Review File COI Form Open Access